Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 1724
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13662(4-chloro-3-[2-(2,4-dichlorophenyl)ethoxy]-5-methox...)
Affinity DataKi:  10nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13663(3-[2-(2,4-dichlorophenyl)ethoxy]-5-methoxy-4-methy...)
Affinity DataKi:  13nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13668(4-chloro-3-[2-(4-chlorophenyl)ethoxy]-N-{[1-(pyrid...)
Affinity DataKi:  13nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13664(3-[2-(2,4-dichlorophenyl)ethoxy]-4-methoxy-N-{[1-(...)
Affinity DataKi:  18nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13615(4-chloro-3-[2-(5-chloropyridin-2-yl)ethoxy]-N-{[1-...)
Affinity DataKi:  20nM ΔG°:  -43.9kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13659(4-bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-5-methoxy...)
Affinity DataKi:  20nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13670(4-chloro-3-[2-(4-chlorophenyl)ethoxy]-5-methoxy-N-...)
Affinity DataKi:  25nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13652(3-[2-(2,4-dichlorophenyl)ethoxy]-4-(methylsulfanyl...)
Affinity DataKi:  28nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13645(4-amino-3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(py...)
Affinity DataKi:  29nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13619(3-[2-(4-bromophenyl)ethoxy]-4-chloro-N-{[1-(pyridi...)
Affinity DataKi:  36nM ΔG°:  -42.5kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13618(3-[2-(5-chloropyridin-2-yl)ethoxy]-4-fluoro-N-{[1-...)
Affinity DataKi:  37nM ΔG°:  -42.4kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13642(3-[2-(2,4-dichlorophenyl)ethoxy]-4-methyl-N-{[1-(p...)
Affinity DataKi:  37nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13658(7-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-...)
Affinity DataKi:  39nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13617(3-[2-(4-chlorophenyl)ethoxy]-4-fluoro-N-{[1-(pyrid...)
Affinity DataKi:  40nM ΔG°:  -42.2kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13665(3-[2-(4-chlorophenyl)ethoxy]-4-methoxy-N-{[1-(pyri...)
Affinity DataKi:  41nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13667(4-chloro-3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(p...)
Affinity DataKi:  41nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13644(4-cyano-3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(py...)
Affinity DataKi:  44nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13646(3-[2-(2,4-dichlorophenyl)ethoxy]-4-(methylamino)-N...)
Affinity DataKi:  48nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13616(3-[2-(2,4-dichlorophenyl)ethoxy]-4-fluoro-N-{[1-(p...)
Affinity DataKi:  50nM ΔG°:  -41.7kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13656(3-[2-(2,4-dichlorophenyl)ethoxy]-4,5-dimethoxy-N-{...)
Affinity DataKi:  50nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13651(5-[2-(2,4-dichlorophenyl)ethoxy]-1-N-{[1-(pyridin-...)
Affinity DataKi:  51nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13666(3-[2-(5-chloropyridin-2-yl)ethoxy]-4-methoxy-N-{[1...)
Affinity DataKi:  54nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13673(3-[2-(2,4-dichlorophenyl)ethoxy]-4-methoxy-N-{[1-(...)
Affinity DataKi:  57nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13653(3-[2-(2,4-dichlorophenyl)ethoxy]-4-ethoxy-N-{[1-(p...)
Affinity DataKi:  61nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13629(3-[2-(4-bromophenyl)ethoxy]-4-fluoro-N-{[1-(pyridi...)
Affinity DataKi:  71nM ΔG°:  -40.8kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13647(3-[2-(2,4-dichlorophenyl)ethoxy]-1-N-{[1-(pyridin-...)
Affinity DataKi:  75nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13640(4-bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(py...)
Affinity DataKi:  76nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13660(4-bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-5-ethoxy-...)
Affinity DataKi:  86nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13620(4-chloro-3-[2-(4-fluorophenyl)ethoxy]-N-{[1-(pyrid...)
Affinity DataKi:  102nM ΔG°:  -39.9kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13639(3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-...)
Affinity DataKi:  106nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13674(3-[2-(2,4-dichlorophenyl)ethoxy]-4-methoxy-N-{[1-(...)
Affinity DataKi:  110nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13621(4-chloro-3-[2-(4-methylphenyl)ethoxy]-N-{[1-(pyrid...)
Affinity DataKi:  124nM ΔG°:  -39.4kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13655(3-[2-(2,4-dichlorophenyl)ethoxy]-5-methoxy-N-{[1-(...)
Affinity DataKi:  125nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13643(3-[2-(2,4-dichlorophenyl)ethoxy]-N-{[1-(pyridin-4-...)
Affinity DataKi:  140nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13689(3-[2-(2,4-dichlorophenyl)ethoxy]-N-[(1-ethanimidoy...)
Affinity DataKi:  140nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13671((2S)-5-carbamimidamido-2-({3-[2-(2,4-dichloropheny...)
Affinity DataKi:  153nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13641(3-[2-(2,4-dichlorophenyl)ethoxy]-4-iodo-N-{[1-(pyr...)
Affinity DataKi:  156nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13706(1-({3-[2-(2,4-dichlorophenyl)ethoxy]-4,5-dimethoxy...)
Affinity DataKi:  167nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13687(N-[(1-carbamimidoylpiperidin-4-yl)methyl]-3-[2-(2,...)
Affinity DataKi:  173nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13672(N-[(1-carbamimidoylpiperidin-4-yl)methyl]-3-[2-(2,...)
Affinity DataKi:  189nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13630(4-fluoro-3-[2-(4-fluorophenyl)ethoxy]-N-{[1-(pyrid...)
Affinity DataKi:  203nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13631(4-fluoro-3-[2-(4-methylphenyl)ethoxy]-N-{[1-(pyrid...)
Affinity DataKi:  206nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13654(3-[2-(2,4-dichlorophenyl)ethoxy]-4-(propan-2-yloxy...)
Affinity DataKi:  233nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13657(3-[2-(2,4-dichlorophenyl)ethoxy]-4,5-diethoxy-N-{[...)
Affinity DataKi:  263nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13675(N-{[1-(2-chloropyrimidin-4-yl)piperidin-4-yl]methy...)
Affinity DataKi:  264nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13669(2-bromo-3-[2-(2,4-dichlorophenyl)ethoxy]-5-({[1-(p...)
Affinity DataKi:  285nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13707(1-({3-[2-(2,4-dichlorophenyl)ethoxy]-4-ethoxypheny...)
Affinity DataKi:  306nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13632(4-fluoro-3-[2-(4-methoxyphenyl)ethoxy]-N-{[1-(pyri...)
Affinity DataKi:  307nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13622(4-chloro-3-[2-(4-methoxyphenyl)ethoxy]-N-{[1-(pyri...)
Affinity DataKi:  314nM ΔG°:  -37.1kJ/molepH: 7.8 T: 2°CAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Aventis Pharma Deutschland

LigandPNGBDBM13648(3-[2-(2,4-dichlorophenyl)ethoxy]-4-acetamido-N-{[1...)
Affinity DataKi:  316nMAssay Description:The inhibitory effect of test compound for human fXa was determined by using the chromogenic substrates S-2765. The hydrolysis rates of chromogenic s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/12/2007
Entry Details Article
PubMed
Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: